What’s Next? Five Things To Look Out For In September

Another US Ustekinumab Approval Awaits; Generic Competition To Sprycel On The Horizon

 
• By Dean Rudge

Generics Bulletin previews the most noteworthy and anticipated events for September 2024.

What's Next Image
• Source: Norstella/Citeline

More from Biosimilars

More from Products